Patent · US Active

Composition comprising red cell-derived microparticles and method of treating excessive bleeding

US11241457B2 · kind B2 · utility

0Cited by
6References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2017
Grant dateFeb 8, 2022
Priority date
Expiry dateApr 24, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides a composition comprising red cell-derived microparticles (RMPs) demonstrating acetylcholine esterase (AchE) activity of less than 350 pmol/min/106 particles/uL. The disclosure further provides a method of treating excessive bleeding comprising administering the composition to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.